We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Genedrive Plc | LSE:GDR | London | Ordinary Share | GB00B1VKB244 | ORD 1.5P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
-0.50 | -11.43% | 3.875 | 3.75 | 4.00 | 4.375 | 3.625 | 4.38 | 4,364,023 | 14:48:15 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Coml Physical, Biologcl Resh | 55k | -5.15M | -0.0447 | -0.87 | 4.46M |
Date | Subject | Author | Discuss |
---|---|---|---|
24/9/2020 16:13 | As I said yesterday. When Roger deramps this it flies :) | hooded claw | |
24/9/2020 16:13 | RNS anytime now guys!!!!! | deanmatlazin | |
24/9/2020 15:55 | Have taken a few here today | justtrying1 | |
24/9/2020 15:49 | Guys..the saliva test from Genedrive will be announced anytime now. This will be non invasive, cheap with a very quick turnaround with the result. Once the RNS comes out, the MM will pull the plug and you can hardly buy online. Better to be in now before. Expect a massive upside soon. Buckle up your seat belt! | deanmatlazin | |
24/9/2020 14:48 | Swerves1 - The rise will be massive because the number of issued shares is very low (only 51 million). I would add that colder weather and winter have already arrived; no other sector will prosper better than Covid stocks. Testing will be so scares that I won't be surprised to see Covid shares double or even triple from here. There will be so much demand for testing worldwide that no supplier will be enough. GDR being engaged in many fronts including rapid testing, IMO this is where to be fully invested. | fuji99 | |
24/9/2020 13:27 | Fuji99 - I agree. Major news coming from 3 or 4 different angles. Any 1 of these should propel the share price But when all these come in.....the rise is likely to be massive! So am glad to be holding here.., | swerves1 | |
24/9/2020 11:59 | Swerves1 - Another big news also due is its development of the Rapid, Portable, point of care test for decentralised SARS-CoV-2 testing since March/April this year - - - As the global spread of coronavirus infection continues, it is likely that a variety of diagnostic tools will be needed for direct clinical care via specialist laboratories, hospitals and in the community. It is likely that millions of people will continue to need to be monitored and tested, and high accuracy point of care molecular testing in decentralised settings will play an important role. genedrive will deliver a clinically verified, robust, easy to use assay that can be used on the Genedrive® instrument in decentralised laboratory settings. - - - | fuji99 | |
24/9/2020 11:25 | Exactly......wouldn't like to be out of this when BC validation news lands......or FDA approval......or India orders...Could be a huge rise! | swerves1 | |
24/9/2020 11:23 | Good luck to anyone who want to leave. Don't bang your heads against the wall when your realise you made a mistake and now it's too late though... | fuji99 | |
24/9/2020 10:54 | No news here for a few weeks by that time will be 90p again | roger148 | |
24/9/2020 10:49 | news anytime now. better be in than out. GLA | deanmatlazin | |
24/9/2020 10:34 | If one compares with the August update of GDR Instruction Manual one can see that we have now 2 more companies that approved the methodology: Beckman& Coulter and Cytiva in addition to Qiagen and Macherey-Nagel (from August) . --- | fuji99 | |
24/9/2020 10:01 | SP movement is purely artificial. Buy to Sell ratio is 5:1. So the best way to rip the benefits is to be patient and leave it for a short period. | fuji99 | |
24/9/2020 09:55 | This is GDR just updated Instruction manual. | fuji99 | |
24/9/2020 09:46 | Things are going pretty well with Beckman Coulter, Cytiva and QIAGEN. All three just validated GDR RNA extraction methodology. Check page 3 of attached link: - - - | fuji99 | |
24/9/2020 09:28 | 110p anyone | roger148 | |
24/9/2020 09:09 | buywell is of the opinion that in the wars of the Covid Tests There can be only one | buywell3 | |
24/9/2020 08:58 | In my view this is the only company with huge hopes to produce PCR tests. At present all existing tests are lab tests, not sufficient and taking a long time for the results. GDR is also the only company nearing full approval. | fuji99 | |
24/9/2020 08:51 | BC validation news ready to land any moment now……and then should be fireworks here ?! | swerves1 | |
23/9/2020 22:19 | Your opinion is ? Yes I agree | hooded claw | |
23/9/2020 20:48 | Overvalued | noreply1 | |
23/9/2020 19:35 | It is with great pleasure we share this news. DIVOC Laboratories received NABL certifications and ICMR permission to offer COVID19 testing in our labs. Our NABL certificate is available on request. We are actively looking for partnerships with collection centres to enable offering of COVID19 diagnostic services to our customers. | blackvulture |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions